SI-BONE Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $213.6M+27.8% YoYTTM through 30 Jun 2026
Net Income -$14.6MTTM through 30 Jun 2026
Free Cash Flow -$4.4MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 79.6% |
| EBITDA Margin | -5.3% |
| Operating Margin | -11.1% |
| Net Margin | -6.9% |
Returns
-10.6%ROE
-7.9%ROA
Balance Sheet Health
Debt / Equity0.20x
Current Ratio8.55x
Net Debt-$112.2Mnet cash position
Cash & Equivalents$33.1M
Quality Metrics
Altman Z-Score6.60
Piotroski F-Score6 / 9
FCF Margin-2.1%
Rule of 406.4
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $200.9M
Diluted EPS-$0.33TTMFY2025: $-0.44
Dividend
No dividend
Capital Allocation
R&D Spend$18M
Capex Intensity3.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| United States | $191.1M | +20.6% | |
| International | $9.8M | +11.4% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.